{"disease":{"id":"t-cell-lymphoma-excluding-primary-cutaneous-t-cell-lymphoma","name":"t cell lymphoma excluding primary cutaneous t cell lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00807495","title":"Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}